Renaissance Technologies »

Aligos Therapeutics shares owned by Renaissance Technologies

Quarter-by-quarter ownership of Aligos Therapeutics (ALGS) shares owned by Renaissance Technologies from 13F filings

Historical chart of Renaissance Technologies investment in Aligos Therapeutics

Tip: Access up to 7 years of quarterly data

All positions including Aligos Therapeutics held by Renaissance Technologies consolidated in one spreadsheet with up to 7 years of data

Download as csvDownload consolidated filings csv Download as ExcelDownload consolidated filings xlsx

Quarterly reported holdings in Aligos Therapeutics by Renaissance Technologies

Quarter filed Position value Share count Share price at filing
2024-09-30 $116k 13k 8.66

More positions owned by Renaissance Technologies

Palantir Technologies Cl A (PLTR)
Novo-nordisk A S Adr (NVO)
United Therapeutics Corporation (UTHR)
Apple (AAPL)
Vertex Pharmaceuticals Incorporated (VRTX)
Microsoft Corporation (MSFT)
Verisign (VRSN)
Sprouts Fmrs Mkt (SFM)
Airbnb Com Cl A (ABNB)
NVIDIA Corporation (NVDA)
Exelixis (EXEL)
Franco-Nevada Corporation (FNV)
CBOE Holdings (CBOE)
Fortinet (FTNT)
Meta Platforms Cl A (META)

View all positions for Renaissance Technologies

Top funds holding Aligos Therapeutics

Woodline Partners
Baker Bros. Advisors
Hillhouse Capital Advisors
Acadian Asset Management
Geode Capital Management
Renaissance Technologies
Charles Schwab Investment Management
BlackRock
Bank of America Corporation
CWM
Advisor Group Holdings
AlphaMark Advisors
Jpmorgan Chase & Co
Zrc Wealth Management
Bnp Paribas Arbitrage, Snc

View all funds holding Aligos Therapeutics